Unraveling the Power of NAP-CNB's Machine Learning-enhanced Tumor Neoantigen Prediction
A. Mendez-Perez, A. M. Acosta-Moreno, C. Wert-Carvajal, P. Ballesteros-Cuartero, R. Sanchez-Garcia, J. R. Macias, R. Sanz-Pamplona, R. Alemany, C. O. S. Sorzano, A. Munoz-Barrutia, E. Veiga
This study validates a machine learning platform, NAP-CNB, for identifying tumor neoantigens using RNAseq data, showing improved antitumor responses with multiantigen vaccination.
bioRxiv · Nov 22, 2023Immunology